The ACME Laboratories Ltd. (DSE:ACMELAB)

Bangladesh flag Bangladesh · Delayed Price · Currency is BDT
69.80
-1.70 (-2.38%)
At close: Dec 4, 2025
-5.55%
Market Cap 14.77B
Revenue (ttm) 34.75B
Net Income (ttm) 2.40B
Shares Out 211.60M
EPS (ttm) 11.36
PE Ratio 6.15
Forward PE n/a
Dividend 3.50 (5.01%)
Ex-Dividend Date Nov 19, 2025
Volume 279,615
Average Volume 125,375
Open 71.30
Previous Close 71.50
Day's Range 69.40 - 71.50
52-Week Range 67.90 - 85.90
Beta 0.03
RSI 32.17
Earnings Date Jan 27, 2026

About The ACME Laboratories

The ACME Laboratories Ltd., a pharmaceutical company, engages in the manufacture, market, and distribution of generic pharmaceutical formulation products in Bangladesh. The company offers pharmaceutical products in various therapeutic areas, such as allergic disorders, analgesic, antifribinolytic, anti-infective, antiviral, artificial sweeteners, cardiovascular, central nervous system (CNS), cough and cold, diabetes, eye care and preparations, gastroprokinetic, hepatobiliary, gastrointestinal, gynaecological, hand sanitizers, hormones and stero... [Read more]

Industry Pharmaceutical Preparations
Founded 1954
Employees 9,301
Stock Exchange Dhaka Stock Exchange
Ticker Symbol ACMELAB
Full Company Profile

Financial Performance

In 2024, The ACME Laboratories's revenue was 31.93 billion, an increase of 18.49% compared to the previous year's 26.95 billion. Earnings were 2.46 billion, an increase of 6.62%.

Financial Statements

News

There is no news available yet.